SCHEMBL3325547

SCHEMBL3325547

CCOC(=O)C1=C(C)NC2=C(C(=O)CCC2)C1c1cccc(OC)c1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 12/20 0.72
ALDH1A1 P00352 11/20 0.68
HSD17B10 Q99714 5/20 0.68
HPGD P15428 4/20 0.68
CASP1 P29466 3/20 0.68
CASP7 P55210 3/20 0.68
GAA P10253 2/20 0.68
HTT P42858 1/20 0.66
TP53 P04637 1/20 0.63
POLB P06746 1/20 0.63
TSHR P16473 1/20 0.62
SMN1; SMN2 Q16637 2/20 0.61
BAP1 Q92560 1/20 0.58
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
GPR174 Q9BXC1 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
MAPK1 P28482 1/20 0.57
ACHE P22303 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3323888 0.92 KDM4E (0.68) KDM4EALDH1A1HSD17B10HPGDCASP1
SCHEMBL3325408 0.91 KDM4E (0.65) KDM4EALDH1A1HSD17B10HPGDCASP1
SCHEMBL3329091 0.90 TP53 (0.62) KDM4EALDH1A1HSD17B10HPGDCASP1
SCHEMBL4256064 0.89 KDM4E (0.73) KDM4EALDH1A1HSD17B10HPGDCASP1
SCHEMBL15765866 0.89 KDM4E (0.72) KDM4EALDH1A1HSD17B10HPGDCASP1
SCHEMBL3328920 0.88 GAA (0.71) KDM4EALDH1A1HSD17B10HPGDCASP1
SCHEMBL3324177 0.87 KDM4E (0.69) KDM4EALDH1A1HSD17B10HPGDCASP1
SCHEMBL3320502 0.87 KDM4E (0.69) KDM4EALDH1A1HSD17B10HPGDCASP1
SCHEMBL3004449 0.86 KDM4E (0.68) KDM4EALDH1A1HSD17B10HPGDCASP1
SCHEMBL3323749 0.85 KDM4E (0.86) KDM4EALDH1A1HSD17B10HPGDCASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100119599-A1 POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION ARCHER PHARMACEUTICALS, INC. (US) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100119599-A1 POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION APP, MAPT, PSEN1 KDM4E 4115/4885ALDH1A1 2615/4885HSD17B10 1530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.